Zhejiang Jiuzhou Pharmaceutical (SHA:603456) completed the establishment of a German subsidiary, according to a Tuesday filing with the Shanghai Stock Exchange.
Jiuzhou Pharma Europe has a registered capital of 500,000 euros, and will develop new drugs, import chemicals, and research and develop new products and methods for the European market, among others, the filing said.
Shares closed 4% higher during Tuesday's trading.
Price (RMB): ¥12.75, Change: ¥+0.51, Percent Change: +4.17%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.